Severe aplastic anaemia following hepatitis A

Area of Science:

• Pediatric Hematology
• Viral Hepatitis Research
• Immunology

Background:

• Severe aplastic anemia (SAA) is a rare but life-threatening condition characterized by bone marrow failure.
• Hepatitis A virus (HAV) infection has been anecdotally linked to SAA, but well-documented cases are scarce.
• This study focuses on a pediatric patient with SAA following a confirmed hepatitis A infection.

Observation:

• A 3-year-old child presented with SAA subsequent to a documented hepatitis A infection.
• The patient received standard treatments including oxymetholone, antithymocytic globulin, and methylprednisolone.
• No significant hematologic recovery was observed despite therapeutic interventions.

Findings:

• This case represents the first well-documented instance of severe aplastic anemia directly following a confirmed hepatitis A infection in a pediatric patient.
• The lack of response to immunosuppressive and anabolic therapy underscores the severity and potential unique pathophysiology of HAV-associated SAA.
• The patient ultimately succumbed to pneumonia, a common complication in aplastic anemia due to immune deficiency.

Implications:

• This case reinforces the association between hepatitis A virus infection and the development of severe aplastic anemia, particularly in children.
• It highlights the critical need for further research into the mechanisms underlying viral-induced aplastic anemia.
• Early recognition and potentially novel therapeutic strategies may be crucial for improving outcomes in such cases.